BLUE BIOFUELS, INC. (BIOF)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '13: -17.4K Q2 '13: -21.6K Q3 '13: -82.1K Q4 '13: -2.1M Q1 '14: -1.2M Q2 '14: -1.2M Q3 '14: -609.2K Q4 '14: -4.8M Q1 '15: -1M Q2 '15: -740.6K Q2 '15: -740.6K Q3 '15: -2.3M Q3 '15: -2.3M Q4 '15: -1.2M Q1 '16: -1.3M Q2 '16: -1.5M Q2 '16: -1.5M Q3 '16: -765.7K Q3 '16: -765.7K Q4 '16: -790.3K Q1 '17: -814.2K Q2 '17: -1.1M Q3 '17: -1.5M Q4 '17: -1.5M Q1 '18: -736.3K Q2 '18: -464.9K Q1 '20: -290.6K Q2 '20: -1.2M Q3 '20: -240.6K Q4 '20: -289.5K Q1 '21: -604.8K Q2 '21: -543.2K Q3 '21: -445.9K Q4 '21: -578K Q1 '22: -2M Q2 '22: -718.1K Q3 '22: -582.7K Q4 '22: -598.3K Q1 '23: -1.1M Q2 '23: -1.1M Q3 '23: -512.8K Q4 '23: -505.3K Q1 '24: -903.6K Q2 '24: -541.1K Q3 '24: -647.8K Q4 '24: -2M Q1 '25: -688.8K Q2 '25: -902.6K Q3 '25: -836.3K Q4 '25: -1.3M Q1 '26: -659.5K Q2 '26: -731.1K Q3 '13 Q2 '15 Q2 '16 Q4 '17 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q2 '12: -39.2K Q3 '12: -39.2K Q4 '12: 14K Q1 '13: -19.3K Q2 '13: -23.8K Q3 '13: -87.6K Q4 '13: -2.2M Q1 '14: -1.3M Q2 '14: -2.3M Q3 '14: -1.1M Q4 '14: -5.3M Q1 '15: -395.5K Q2 '15: -807.8K Q2 '15: -807.8K Q3 '15: -2.5M Q3 '15: -2.5M Q4 '15: -1.5M Q1 '16: -684K Q2 '16: -1.6M Q2 '16: -1.6M Q3 '16: -807.7K Q3 '16: -807.7K Q4 '16: -5.3M Q1 '17: -511.5K Q2 '17: -1.6M Q3 '17: -2M Q4 '17: -6.1M Q1 '18: -1.3M Q2 '18: -860K Q1 '20: -397.9K Q2 '20: -1.2M Q3 '20: -253.6K Q4 '20: -323.4K Q1 '21: -613.6K Q2 '21: -485.5K Q3 '21: -454.2K Q4 '21: -586K Q1 '22: -2M Q2 '22: -725.4K Q3 '22: -618.7K Q4 '22: -575.1K Q1 '23: -1.1M Q2 '23: -1.2M Q3 '23: -332K Q4 '23: -504.9K Q1 '24: -946.9K Q2 '24: -548.8K Q3 '24: 1.9M Q4 '24: -1.8M Q1 '25: -243.8K Q2 '25: -920.8K Q3 '25: -422.5K Q4 '25: -1.3M Q1 '26: -663.8K Q2 '26: -750.8K Q3 '13 Q2 '15 Q2 '16 Q4 '17 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-1.2M -800K -400K 0 400K 800K 1.2M Q3 '12: -77.9K Q4 '12: -12.7K Q1 '13: -18.8K Q2 '13: -21.6K Q3 '13: -80.1K Q4 '13: -397K Q1 '14: -519.3K Q2 '14: -725.2K Q3 '14: -778.7K Q4 '14: -853.1K Q1 '15: -435.6K Q2 '15: -490.6K Q3 '15: -877.7K Q4 '15: -209K Q1 '16: -835.4K Q2 '16: -525.1K Q3 '16: -472K Q4 '16: -412.3K Q1 '17: -464.6K Q2 '17: -646.8K Q3 '17: -435.5K Q4 '17: -297.3K Q1 '18: -406.7K Q2 '18: -248.5K Q1 '20: -162.6K Q2 '20: -250.1K Q3 '20: -252K Q4 '20: -256.7K Q1 '21: -1.1M Q2 '21: -508.6K Q3 '21: -462.6K Q4 '21: -441.9K Q1 '22: -530K Q2 '22: -675.9K Q3 '22: -380.3K Q4 '22: -449.9K Q1 '23: -609.1K Q2 '23: -571.5K Q3 '23: -313.9K Q4 '23: -105.9K Q1 '24: -255.9K Q2 '24: -287.5K Q3 '24: -248K Q4 '24: -212K Q1 '25: 13.4K Q2 '25: -312.1K Q3 '25: -154K Q4 '25: -392.3K Q1 '26: -418.5K Q2 '26: -268.8K Q3 '12 Q2 '14 Q1 '16 Q4 '17 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q1 '14: -519.4K Q2 '14: -760K Q3 '14: -796.1K Q4 '14: -939.7K Q1 '15: -621.2K Q2 '15: -550.5K Q3 '15: -906.2K Q4 '15: -211.8K Q1 '16: -841.6K Q2 '16: -536.9K Q3 '16: -472K Q4 '16: -412.3K Q1 '17: -472.6K Q2 '17: -646.8K Q3 '17: -435.5K Q4 '17: -297.3K Q1 '18: -422K Q2 '18: -251.4K Q3 '21: -526.7K Q4 '21: -479.5K Q1 '22: -533.6K Q2 '22: -677.1K Q3 '22: -439.7K Q4 '22: -526.3K Q1 '23: -891.2K Q2 '23: -571.5K Q3 '23: -313.9K Q4 '23: -111.7K Q1 '25: -91.2K Q2 '25: -343.7K Q3 '25: -221.2K Q4 '25: -392.3K Q4 '14 Q4 '15 Q4 '16 Q4 '17 Q4 '21 Q4 '22 Q4 '23 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '17: 72.9M Q2 '18: 134M Q2 '20: 224.1M Q3 '20: 224.1M Q1 '21: 260.7M Q2 '21: 266.5M Q3 '21: 268.5M Q1 '22: 274.3M Q2 '22: 331.5M Q3 '22: 277.4M Q1 '23: 295M Q2 '23: 300.2M Q3 '23: 299.8M Q1 '24: 302.8M Q2 '24: 302.8M Q3 '24: 316.9M Q1 '25: 308.5M Q2 '25: 310M Q3 '25: 312.2M Q1 '26: 319.2M Q2 '26: 321.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.30 -0.20 -0.10 0.00 0.10 0.20 0.30 Q4 '13: -0.10 Q1 '14: -0.14 Q2 '14: -0.21 Q3 '14: -0.24 Q4 '14: -0.28 Q1 '15: -0.25 Q2 '15: -0.20 Q2 '16: -0.16 Q2 '17: -0.13 Q3 '17: -0.14 Q4 '17: -0.13 Q1 '18: -0.13 Q2 '18: -0.12 Q4 '20: -0.01 Q1 '21: -0.01 Q2 '21: -0.01 Q3 '21: -0.01 Q4 '21: -0.01 Q1 '22: -0.01 Q2 '22: -0.01 Q3 '22: -0.01 Q4 '22: -0.01 Q1 '23: -0.01 Q2 '23: -0.01 Q3 '23: -0.01 Q4 '23: -0.01 Q1 '24: -0.01 Q2 '24: -0.01 Q3 '24: -0.00 Q4 '24: -0.01 Q1 '25: -0.00 Q2 '25: -0.00 Q3 '25: -0.01 Q4 '25: -0.01 Q1 '26: -0.01 Q2 '26: -0.01 Q4 '13 Q1 '15 Q4 '17 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.